STOCK TITAN

Proposed sale of 64,540 common shares under registered plan (RYTM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RYTM filing reports a proposed sale of 64,540 common shares on 03/04/2026 described as an exercise of options under a registered plan. The filing also records a sale of 35,460 common shares by Camille L. Bedrosian on 03/03/2026 for $3,209,778.92.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notes a brokered resale following option exercise and a recent insider sale.

The entry lists 64,540 common shares to be sold on 03/04/2026, described verbatim as an exercise of options under a registered plan. This indicates shares resulting from option exercise are being presented for resale.

Examples shown include a prior sale by Camille L. Bedrosian of 35,460 shares on 03/03/2026 for $3,209,778.92. Subsequent filings will disclose actual sale completion and methods.

The notice follows standard resale procedures for restricted or control securities.

The excerpt lists Morgan Stanley Smith Barney LLC and identifies the transaction as involving the issuer and an exercise under a registered plan, verbatim. The broker line and plan descriptor align with routine resale mechanics.

Regulatory outcome depends on timing and transaction reporting; this filing documents intent rather than confirmed settlement.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the RYTM Form 144 say was offered for sale?

The filing reports a proposed sale of 64,540 common shares on 03/04/2026 from an exercise of options under a registered plan. This describes the source of the shares and the proposed sale date without listing final settlement details.

Who recently sold RYTM shares according to the filing?

The filing shows Camille L. Bedrosian sold 35,460 common shares on 03/03/2026 for $3,209,778.92. That transaction is recorded in the "Securities Sold During The Past 3 Months" section as provided in the excerpt.

Was the RYTM sale related to option exercise?

Yes. The proposed sale of 64,540 shares is explicitly described as an exercise of options under a registered plan with a listed date of 03/04/2026. The phrase is used verbatim in the filing excerpt.

Which broker-dealer appears in the RYTM Form 144?

The excerpt lists Morgan Stanley Smith Barney LLC with an address line under the securities section. The broker-dealer name appears alongside the securities-to-be-sold entry on 03/04/2026 as shown in the content.

Does the filing confirm settlement or proceeds recipient for the 64,540 shares?

The excerpt identifies the proposed sale and its source but does not state settlement confirmation or the recipient of proceeds for the 64,540 shares. The line reads "Issuer" and lists the exercise descriptor without settlement details.
Rhythm Pharmaceu

NASDAQ:RYTM

View RYTM Stock Overview

RYTM Rankings

RYTM Latest News

RYTM Latest SEC Filings

RYTM Stock Data

6.35B
63.38M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON